Sabag Mark
See "Remarks"
Sabag Mark has filed 6 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: May 4, 2026.
On the most recent filing, Sabag Mark is listed as See "Remarks" at TEVA PHARMACEUTICAL INDUSTRIES LTD. Inside the rolling window, Sabag Mark reported no open-market purchases and 3 open-market sales totaling $13.1M in TEVA. The largest disclosed transaction in the window is a sale of 216,892 TEVA shares on Dec 9, 2025, worth $6.2M.
Companies traded
Other insiders at TEVA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$13.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sabag Mark made?
Sabag Mark has filed 6 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does Sabag Mark trade?
Sabag Mark has filed SEC Form 4 disclosures for 1 company, including TEVA.
When was Sabag Mark's most recent SEC Form 4 filing?
Sabag Mark's most recent SEC Form 4 filing on Tracefour is dated May 4, 2026.
What is Sabag Mark's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sabag Mark is listed as See "Remarks".
What is Sabag Mark's total buy and sell value in the current window?
Inside the rolling retention window, Sabag Mark bought $0 and sold $13.1M based on SEC Form 4 filings.
What was Sabag Mark's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 216,892 TEVA shares on 2025-12-09, worth $6.2M, per SEC Form 4 filings.